Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Clinical trial NCT05185804 · COMPLETED

Trial details

NCT number: NCT05185804
Sponsor: PharmaDiall Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Venous Thromboembolism

Start date: 2021-02-08
Primary completion: 2021-08-06
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.